Biomarkers and attention-deficit/hyperactivity disorder: A systematic review and meta-analyses

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 51, Issue 10, 2012, Pages 1003-1019.e20

  Scassellati, Catia ^a   Bonvicini, Cristian ^a   Faraone, Stephen V ^b   Gennarelli, Massimo ^a,c  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

attention deficit hyperactivity disorder; biochemical markers; diagnosis; drug treatment efficacy; meta analyses

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; AMINE OXIDASE (FLAVIN CONTAINING); BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; COMPLEMENT COMPONENT C4B; DOPA; DOPAMINE; DOPAMINE BETA MONOOXYGENASE; ESSENTIAL FATTY ACID; FERRITIN; HEAVY METAL; HOMOVANILLIC ACID; HYDROCORTISONE; LEAD; MAGNESIUM; MANGANESE; MELATONIN; MESSENGER RNA; METADRENALIN; NEUROPEPTIDE Y; NORADRENALIN; POLYUNSATURATED FATTY ACID; PRASTERONE; TRACE ELEMENT; VANILMANDELIC ACID;

ATTENTION DEFICIT DISORDER; CEREBROSPINAL FLUID ANALYSIS; COGNITION; COMORBIDITY; DEMOGRAPHY; DISEASE SEVERITY; EFFECT SIZE; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; META ANALYSIS; MONOAMINERGIC SYSTEM; NEUROPHYSIOLOGY; NEUROTRANSMISSION; NUTRITIONAL STATUS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW;

EID: 84867002677     PISSN: 08908567     EISSN: 15275418     Source Type: Journal    
DOI: 10.1016/j.jaac.2012.08.015     Document Type: Review

References (201)

1. H.D. Schmidt, R.C. Shelton, R.S. Duman Functional biomarkers of depression: diagnosis, treatment, and pathophysiology Neuropsychopharmacology 36 2011 2375 2394
2. W.O. Shekim, E. Sinclair, R. Glaser, E. Horwitz, J. Javaid, D.B. Bylund Norepinephrine and dopamine metabolites and educational variables in boys with attention deficit disorder and hyperactivity J Child Neurol 2 1987 50 56
3. T.D. Eppright, S.J. Vogel, E. Horwitz, H.D. Tevendale Results of blood lead screening in children referred for behavioral disorders Mod Med 94 1997 295 297
4. M. Egger, G.D. Smith, A.N. Phillips Meta-analysis: principles and procedures BMJ 315 1997 1533 1537
5. T.E. Froehlich, J.S. Anixt, I.M. Loe, V. Chirdkiatgumchai, L. Kuan, R.C. Gilman Update on environmental risk factors for attention-deficit/hyperactivity disorder Curr Psychiatry Rep 13 2011 333 344
6. P.H. Wender, R.S. Epstein, I.J. Kopin, E.K. Gordon Urinary monoamine metabolites in children with minimal brain dysfunction Am J Psychiatry 127 1971 1411 1415
7. W.O. Shekim, H. Dekirmenjian, J.L. Chapel Urinary catecholamine metabolites in hyperkinetic boys treated with d-amphetamine Am J Psychiatry 134 1977 1276 1279
8. J.L. Rapoport, E.J. Mikkelsen, M.H. Ebert, G.L. Brown, V.K. Weise, I.J. Kopin Urinary catecholamines and amphetamine excretion in hyperactive and normal boys J Nerv Ment Dis 166 1978 731 737
9. W.O. Shekim, H. Dekirmenjian, J.L. Chapel Urinary MHPG excretion in the hyperactive child syndrome and the effects of dextroamphetamine [proceedings] Psychopharmacol Bull 14 1978 42 44
10. W.O. Shekim, H. Dekirmenjian, J.L. Chapel, J. Javaid, J.M. Davis Norepinephrine metabolism and clinical response to dextroamphetamine in hyperactive boys J Pediatr 95 1979 389 394
11. W.O. Shekim, H. Dekirmenjian, J.L. Chapel Urinary MHPG excretion in minimal brain dysfunction and its modification by d-amphetamine Am J Psychiatry 136 1979 667 671
12. A.U. Khan, H. Dekirmenjian Urinary excretion of catecholamine metabolites in hyperkinetic child syndrome Am J Psychiatry 138 1981 108 110
13. W.O. Shekim, J. Javaid, H. Dekirmenjian, J.L. Chapel, J.M. Davis Effects of d-amphetamine on urinary metabolites of dopamine and norepinephrine in hyperactive boys Am J Psychiatry 139 1982 485 488
14. W.O. Shekim, H. Dekirmenjian, J. Javaid, D.B. Bylund, J.M. Davis Dopamine-norepinephrine interaction in hyperactive boys treated with d-amphetamine J Pediatr 100 1982 830 844
15. W.O. Shekim, J. Javaid, J.M. Davis, D.B. Bylund Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine Biol Psychiatry 18 1983 707 714
16. Y.C. Shen, Y.F. Wang Urinary 3-methoxy-4-hydroxyphenylglycol sulfate excretion in seventy-three schoolchildren with minimal brain dysfunction syndrome Biol Psychiatry 19 1984 861 870
17. G.B. Baker, R.A. Bornstein, A.B. Douglass, J.C. Van Muyden, S. Ashton, T.L. Bazylewich Urinary excretion of MHPG and normetanephrine in attention deficit hyperactivity disorder Mol Chem Neuropathol 18 1993 173 178
18. R.D. Oades, B. Müller The development of conditioned blocking and monoamine metabolism in children with attention-deficit-hyperactivity disorder or complex tics and healthy controls: an exploratory analysis Behav Brain Res 88 1997 95 102
19. R.D. Oades, R. Daniels, W. Rascher Plasma neuropeptide-Y levels, monoamine metabolism, electrolyte excretion and drinking behavior in children with attention-deficit hyperactivity disorder Psychiatry Res 80 1998 177 186
20. A. Kusaga, Y. Yamashita, T. Koeda Increased urine phenylethylamine after methylphenidate treatment in children with ADHD Ann Neurol 52 2002 372 374
21. W.O. Shekim, L.G. Davis, D.B. Bylund, E. Brunngraber, L. Fikes, J. Lanham Platelet MAO in children with attention deficit disorder and hyperactivity: a pilot study Am J Psychiatry 139 1982 936 938
22. W.O. Shekim, D.B. Bylund, J. Alexson Platelet MAO and measures of attention and impulsivity in boys with attention deficit disorder and hyperactivity Psychiatry Res 18 1986 179 188
23. C.L. Bowden, C.K. Deutsch, J.M. Swanson Plasma dopamine-beta-hydroxylase and platelet monoamine oxidase in attention deficit disorder and conduct disorder J Am Acad Child Adolesc Psychiatry 27 1988 171 174
24. T. Coccini, A. Crevani, G. Rossi Reduced platelet monoamine oxidase type B activity and lymphocyte muscarinic receptor binding in unmedicated children with attention deficit hyperactivity disorder Biomarkers 14 2009 513 522
25. G. Nedic, N. Pivac, D.K. Hercigonja, M. Jovancevic, K.D. Curkovic, D. Muck-Seler Platelet monoamine oxidase activity in children with attention-deficit/hyperactivity disorder Psychiatry Res 175 2010 252 255
26. L.M. Jansen, C.C. Gispen-de Wied, M.A. Jansen, R.J. van der Gaag, W. Matthys, H. van Engeland Pituitary-adrenal reactivity in a child psychiatric population: salivary cortisol response to stressors Eur Neuropsychopharmacol 9 1999 67 75
27. H. Snoek, S.H. Van Goozen, W. Matthys, J.K. Buitelaar, H. van Engeland Stress responsivity in children with externalizing behavior disorders Dev Psychopathol 16 2004 389 406
28. M. Blomqvist, K. Holmberg, F. Lindblad, E. Fernell, U. Ek, G. Dahllöf Salivary cortisol levels and dental anxiety in children with attention deficit hyperactivity disorder Eur J Oral Sci 115 2007 1 6
29. D. van West, S. Claes, D. Deboutte Differences in hypothalamic-pituitary- adrenal axis functioning among children with ADHD predominantly inattentive and combined types Eur Child Adolesc Psychiatry 18 2009 543 553
30. C.M. Freitag, S. Hänig, H. Palmason, J. Meyer, S. Wüst, C. Seitz Cortisol awakening response in healthy children and children with ADHD: impact of comorbid disorders and psychosocial risk factors Psychoneuroendocrinology 34 2009 1019 1028
31. E.F. Maldonado, M.V. Trianes, A. Cortés, E. Moreno, M. Escobar Salivary cortisol response to a psychosocial stressor on children diagnosed with attention-deficit/hyperactivity disorder: differences between diagnostic subtypes Span J Psychol 12 2009 707 714
32. H. Christiansen, R.D. Oades, L. Psychogiou, B.P. Hauffa, E.J. Sonuga-Barke Does the cortisol response to stress mediate the link between expressed emotion and oppositional behavior in attention-deficit/hyperactivity- disorder (ADHD)? Behav Brain Funct 6 2010 45
33. L.J. Wang, Y.S. Huang, C.C. Hsiao Salivary dehydroepiandrosterone, but not cortisol, is associated with attention deficit hyperactivity disorder World J Biol Psychiatry 12 2011 99 109
34. G.L. Hanna, E.M. Ornitz, M. Hariharan Urinary epinephrine excretion during intelligence testing in attention-deficit hyperactivity disorder and normal boys Biol Psychiatry 40 1996 553 555
35. G.L. Hanna, E.M. Ornitz, M. Hariharan Urinary catecholamine excretion and behavioral differences in ADHD and normal boys J Child Adolesc Psychopharmacol 6 1996 63 73
36. M. Dvoráková, D. Jezová, P. Blazícek Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): modulation by a polyphenolic extract from pine bark (pycnogenol) Nutr Neurosci 10 2007 151 157
37. G. Ionescu, R. Kiehl, L. Ona, F. Wichmann-Kunz Abnormal plasma catecholamines in hyperkinetic children Biol Psychiatry 28 1990 547 550
38. S.B. Wigal, D. Nemet, J.M. Swanson Catecholamine response to exercise in children with attention deficit hyperactivity disorder Pediatr Res 53 2003 756 761
39. T. Shetty, T.N. Chase Central monoamines and hyperkinesis of childhood Neurology 26 1976 1000 1002
40. B.A. Shaywitz, D.J. Cohen, M.B. Bowers Jr CSF monoamine metabolites in children with minimal brain dysfunction: evidence for alteration of brain dopamine A preliminary report J Pediatr 90 1977 67 71
41. J.L. Rapoport, I.T. Lott, D.F. Alexander, A.U. Abramson Urinary noradrenaline and playroom behaviour in hyperactive boys Lancet 2 1970 1141
42. K. Konrad, S. Gauggel, J. Schurek Catecholamine functioning in children with traumatic brain injuries and children with attention-deficit/hyperactivity disorder Brain Res Cogn Brain Res 16 2003 425 433
43. S.R. Pliszka, J.W. Maas, M.A. Javors, G.A. Rogeness, J. Baker Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety J Am Acad Child Adolesc Psychiatry 33 1994 1165 1173
44. N.L. Girardi, S.E. Shaywitz, B.A. Shaywitz Blunted catecholamine responses after glucose ingestion in children with attention deficit disorder Pediatr Res 38 1995 539 542
45. K.P. Lesch, S. Selch, T.J. Renner Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree Mol Psychiatry 16 2011 491 503
46. N. Bhaduri, K. Sarkar, S. Sinha, A. Chattopadhyay, K. Mukhopadhyay Study on DBH genetic polymorphisms and plasma activity in attention deficit hyperactivity disorder patients from Eastern India Cell Mol Neurobiol 30 2010 265 274
47. I. Paclt, J. Koudelová, D. Pacltova, M. Kopeckova Dopamine beta hydroxylase (DBH) plasma activity in childhood mental disorders Neuro Endocrinol Lett 30 2009 604 609
48. M. Donnelly, J.L. Rapoport, W.Z. Potter, J. Oliver, C.S. Keysor, D.L. Murphy Fenfluramine and dextroamphetamine treatment of childhood hyperactivity Clinical and biochemical findings Arch Gen Psychiatry 46 1989 205 212
49. D.F. Klein, R. Gittelman, F. Quitkin Diagnosis and drug treatment of childhood disorders, in Diagnosis and Drug treatment of Psychiatric Disorders: Adults and Children 1980 Williams & Wilkins Co Baltimore
50. J. Rapoport, P. Quinn, N. Scribanu, D.L. Murphy Platelet serotonin of hyperactive school age boys Br J Psychiatry 125 1974 138 140
51. V. Hercigonja Novkovic, V. Rudan, N. Pivac, G. Nedic, D. Muck-Seler Platelet serotonin concentration in children with attention-deficit/ hyperactivity disorder Neuropsychobiology 59 2009 17 22
52. H.N. Bhagavan, M. Coleman, D.B. Coursin The effect of pyridoxine hydrochloride on blood serotonin and pyridoxal phosphate contents in hyperactive children Pediatrics 55 1975 437 441
53. H.B. Ferguson, B.A. Pappas, R.L. Trites, D.A. Peters, H. Taub Plasma free and total tryptophan, blood serotonin, and the hyperactivity syndrome: no evidence for the serotonin deficiency hypothesis Biol Psychiatry 16 1981 231 238
54. R.D. Oades, A.M. Myint, M.R. Dauvermann, B.G. Schimmelmann, M.J. Schwarz Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention Behav Brain Funct 6 2010 32
55. R.D. Oades, M.R. Dauvermann, B.G. Schimmelmann, M.J. Schwarz, A.M. Myint Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism - effects of medication Behav Brain Funct 6 2010 29
56. Y. Hoshino, Y. Ohno, T. Yamamoto, M. Kaneko, H. Kumashiro Plasma free tryptophan concentration in children with attention deficit disorder Folia Psychiatr Neurol Jpn 39 1985 531 535
57. A.J. Zametkin, F. Karoum, J.L. Rapoport, G.L. Brown, R.J. Wyatt Phenylethylamine excretion in attention deficit disorder J Am Acad Child Psychiatry 23 1984 310 314
58. G.B. Baker, R.A. Bornstein, A.C. Rouget, S.E. Ashton, J.C. van Muyden, R.T. Coutts Phenylethylaminergic mechanisms in attention-deficit disorder Biol Psychiatry 29 1991 15 22
59. M.D. Berry Mammalian central nervous system trace amines Pharmacologic amphetamines, physiologic neuromodulators J Neurochem 90 2004 257 271
60. A.J. Zametkin, G.L. Brown, F. Karoum Urinary phenethylamine response to d-amphetamine in 12 boys with attention deficit disorder Am J Psychiatry 141 1984 1055 1058
61. P.A. Eubig, A. Aguiar, S.L. Schantz Lead and PCBs as risk factors for attention deficit/hyperactivity disorder Environ Health Perspect 118 2010 1654 1667
62. J.T. Nigg, G.M. Knottnerus, M.M. Martel Low blood lead levels associated with clinically diagnosed attention-deficit/hyperactivity disorder and mediated by weak cognitive control Biol Psychiatry 63 2008 325 331
63. J.T. Nigg, M. Nikolas, G. Mark Knottnerus, K. Cavanagh, K. Friderici Confirmation and extension of association of blood lead with attention-deficit/hyperactivity disorder (ADHD) and ADHD symptom domains at population-typical exposure levels J Child Psychol Psychiatry 51 2010 58 65
64. H.L. Wang, X.T. Chen, B. Yang Case-control study of blood lead levels and attention deficit hyperactivity disorder in Chinese children Environ Health Perspect 116 2008 1401 1406
65. A.C. Farias, A. Cunha, C.R. Benko Manganese in children with attention-deficit/hyperactivity disorder: relationship with methylphenidate exposure J Child Adolesc Psychopharmacol 20 2010 113 118
66. E. Konofal, M. Lecendreux, I. Arnulf, M.C. Mouren Iron deficiency in children with attention-deficit/hyperactivity disorder Arch Pediatr Adolesc Med 158 2004 1113 1115
67. E. Konofal, S. Cortese, M. Marchand, M.C. Mouren, I. Arnulf, M. Lecendreux Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children Sleep Med 8 2007 711 715
68. J.G. Millichap, M.M. Yee, S.I. Davidson Serum ferritin in children with attention-deficit hyperactivity disorder Pediatr Neurol 34 2006 200 203
69. J.Y. Kiddie, M.D. Weiss, D.D. Kitts, R. Levy-Milne, M.B. Wasdell Nutritional status of children with attention deficit hyperactivity disorder: a pilot study Int J Pediatr 2010 767318
70. M. Menegassi, E.D. Mello, L.R. Guimarães Food intake and serum levels of iron in children and adolescents with attention-deficit/hyperactivity disorder Rev Bras Psiquiatr 32 2010 132 138
71. M. Juneja, R. Jain, V. Singh, V. Mallika Iron deficiency in Indian children with attention deficit hyperactivity disorder Indian Pediatr 47 2010 955 958
72. S. Cortese, R. Azoulay, F.X. Castellanos Brain iron levels in attention-deficit/hyperactivity disorder: a pilot MRI study World J Biol Psychiatry 13 2012 223 231
73. O. Oner, P. Oner, O.H. Bozkurt Effects of zinc and ferritin levels on parent and teacher reported symptom scores in attention deficit hyperactivity disorder Child Psychiatry Hum Dev 41 2010 441 447
74. S. Grantham-McGregor, C. Ani A review of studies on the effect of iron deficiency on cognitive development in children J Nutr 131 2001 649S 666S
75. M. Bekarolu, Y. Aslan, Y. Gedik Relationships between serum free fatty acids and zinc, and attention deficit hyperactivity disorder: a research note J Child Psychol Psychiatry 37 1996 225 227
76. P. Toren, S. Eldar, B.A. Sela Zinc deficiency in attention-deficit hyperactivity disorder Biol Psychiatry 40 1996 1308 1310
77. O. Yorbik, M.F. Ozdag, A. Olgun, M.G. Senol, S. Bek, S. Akman Potential effects of zinc on information processing in boys with attention deficit hyperactivity disorder Prog Neuropsychopharmacol Biol Psychiatry 32 2008 662 667
78. A. Viktorinova, J. Trebaticka, Z. Paduchova Natural polyphenols modify trace element status and improve clinical symptoms of attention-deficit hyperactivity disorder [published online October 20, 2009] Biomed Pharmacother 2009 http://dx.doi.org/10.1016/j.biopha.2009.04.040
79. L.E. Arnold, N.A. Votolato, D. Kleykamp, G.B. Baker, R.A. Bornstein Does hair zinc predict amphetamine improvement of ADD/hyperactivity? Int J Neurosci 50 1990 103 107
80. L.E. Arnold, R.A. DiSilvestro Zinc in attention-deficit/hyperactivity disorder J Child Adolesc Psychopharmacol 15 2005 619 627
81. Y. Uçkardeş, E.N. Ozmert, F. Unal, K. Yurdakök Effects of zinc supplementation on parent and teacher behaviour rating scores in low socioeconomic level Turkish primary school children Acta Paediatr 98 2009 731 736
82. T. Kozielec, B. Starobrat-Hermelin Assessment of magnesium levels in children with attention deficit hyperactivity disorder (ADHD) Magnes Res 10 1997 143 148
83. G. Irmisch, J. Thome, O. Reis, F. Hässler, S. Weirich Modified magnesium and lipoproteins in children with attention deficit hyperactivity disorder (ADHD) World J Biol Psychiatry 12 Suppl 1 2011 63 65
84. E. Archana, P. Pai, B.K. Prabhu, R.P. Shenoy, K. Prabhu, A. Rao Altered biochemical parameters in saliva of pediatric attention deficit hyperactivity disorder Neurochem Res 37 2012 330 334
85. E.A. Mitchell, S. Lewis, D.R. Cutler Essential fatty acids and maladjusted behaviour in children Prostaglandins Leukot Med 12 1983 281 287
86. L.J. Stevens, S.S. Zentall, J.L. Deck Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder Am J Clin Nutr 62 1995 761 768
87. L. Stevens, W. Zhang, L. Peck EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors Lipids 38 2003 1007 1021
88. J.R. Chen, S.F. Hsu, C.D. Hsu, L.H. Hwang, S.C. Yang Dietary patterns and blood fatty acid composition in children with attention-deficit hyperactivity disorder in Taiwan J Nutr Biochem 15 2004 467 472
89. K. Joshi, S. Lad, M. Kale Supplementation with flax oil and vitamin C improves the outcome of Attention Deficit Hyperactivity Disorder (ADHD) Prostaglandins Leukot Essent Fatty Acids 74 2006 17 21
90. M. Germano, D. Meleleo, G. Montorfano Plasma, red blood cells phospholipids and clinical evaluation after long chain omega-3 supplementation in children with attention deficit hyperactivity disorder (ADHD) Nutr Neurosci 10 2007 1 9
91. A.L. Colter, C. Cutler, K.A. Meckling Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study Nutr J 7 2008 8
92. S. Spahis, M. Vanasse, S.A. Bélanger, P. Ghadirian, E. Grenier, E. Levy Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder Prostaglandins Leukot Essent Fatty Acids 79 2008 47 53
93. E.A. Mitchell, M.G. Aman, S.H. Turbott, M. Manku Clinical characteristics and serum essential fatty acid levels in hyperactive children Clin Pediatr (Phila) 26 1987 406 411
94. N. Pivac, A. Knezević, O. Gornik Human plasma glycome in attention-deficit hyperactivity disorder and autism spectrum disorders Mol Cell Proteomics 10 2011 M110.004200
95. M.H. Bloch, A. Qawasmi Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis J Am Acad Child Adolesc Psychiatry 50 2011 991 1000
96. A.M. McCarthy, K. Hanrahan, L.M. Scott, N. Zemblidge, C. Kleiber, M.B. Zimmerman Salivary cortisol responsivity to an intravenous catheter insertion in children with attention-deficit/hyperactivity disorder J Pediatr Psychol 36 2011 902 910
97. M.J. Kruesi, M.E. Schmidt, M. Donnelly, E.D. Hibbs, S.D. Hamburger Urinary free cortisol output and disruptive behavior in children J Am Acad Child Adolesc Psychiatry 28 1989 441 443
98. L. Ma, Y.H. Chen, H. Chen, Y.Y. Liu, Y.X. Wang The function of hypothalamus-pituitary-adrenal axis in children with ADHD Brain Res 1368 2011 159 162
99. S.H. Kariyawasam, F. Zaw, S.L. Handley Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder Neuro Endocrinol Lett 23 2002 45 48
100. L.J. Wang, C.C. Hsiao, Y.S. Huang Association of salivary dehydroepiandrosterone levels and symptoms in patients with attention deficit hyperactivity disorder during six months of treatment with methylphenidate Psychoneuroendocrinology 36 2011 1209 1216
101. M.S. Lee, J.W. Yang, Y.H. Ko Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder Child Psychiatry Hum Dev 39 2008 201 209
102. S.V. Faraone, E. Mick Molecular genetics of attention deficit hyperactivity disorder Psychiatr Clin North Am 33 2010 159 180
103. L. Hubbs-Tait, T.S. Kennedy, E.A. Droke, D.M. Belanger, J.R. Parker Zinc, iron, and lead: relations to head start children's cognitive scores and teachers' ratings of behavior J Am Diet Assoc 107 2007 128 133
104. E. Konofal, S. Cortese Lead and neuroprotection by iron in ADHD Environ Health Perspect 115 2007 A398 A399
105. S.R. Pliszka, J.T. McCracken, J.W. Maas Catecholamines in attention-deficit hyperactivity disorder: current perspectives J Am Acad Child Adolesc Psychiatry 35 1996 264 272
106. D.T. Marc, J.W. Ailts, D.C. Campeau, M.J. Bull, K.L. Olson Neurotransmitters excreted in the urine as biomarkers of nervous system activity: validity and clinical applicability Neurosci Biobehav Rev 35 2011 635 644
107. U.E. Lang, R. Hellweg, F. Seifert, F. Schubert, J. Gallinat Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity Biol Psychiatry 62 2007 530 535
108. N.M. Williams, B. Franke, E. Mick Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of rare variants and duplications at 15q13.3 Am J Psychiatry 169 2012 195 204
109. J.G. Millichap, M.M. Yee The diet factor in attention-deficit/ hyperactivity disorder Pediatrics 129 2012 330 337
110. L.E. Arnold, R.A. Disilvestro, D. Bozzolo Zinc for attention-deficit/ hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine J Child Adolesc Psychopharmacol 21 2011 1 19
111. K.K. Zakzanis Brain is related to behavior (p<.05) J Clin Exp Neuropsychol 20 1998 419 427
112. J.L. Rapoport, I.T. Lott, D.F. Alexander, A.U. Abramson Urinary noradrenaline and playroom behaviour in hyperactive boys Lancet 2 1970 1141
113. P.H. Wender, R.S. Epstein, I.J. Kopin, E.K. Gordon Urinary monoamine metabolites in children with minimal brain dysfunction Am J Psychiatry 127 1971 1411 1415
114. J. Rapoport, P. Quinn, N. Scribanu, D.L. Murphy Platelet serotonin of hyperactive school age boys Br J Psychiatry 125 1974 138 140
115. H.N. Bhagavan, M. Coleman, D.B. Coursin The effect of pyridoxine hydrochloride on blood serotonin and pyridoxal phosphate contents in hyperactive children Pediatrics 55 1975 437 441
116. T. Shetty, T.N. Chase Central monoamines and hyperkinesis of childhood Neurology 26 1976 1000 1002
117. B.A. Shaywitz, D.J. Cohen, M.B. Bowers Jr CSF monoamine metabolites in children with minimal brain dysfunction: evidence for alteration of brain dopamine A preliminary report J Pediatr 90 1977 67 71
118. W.O. Shekim, H. Dekirmenjian, J.L. Chapel Urinary catecholamine metabolites in hyperkinetic boys treated with d-amphetamine Am J Psychiatry 134 1977 1276 1279
119. J.L. Rapoport, E.J. Mikkelsen, M.H. Ebert, G.L. Brown, V.K. Weise, I.J. Kopin Urinary catecholamines and amphetamine excretion in hyperactive and normal boys J Nerv Ment Dis 166 1978 731 737
120. W.O. Shekim, H. Dekirmenjian, J.L. Chapel Urinary MHPG excretion in the hyperactive child syndrome and the effects of dextroamphetamine [proceedings] Psychopharmacol Bull 14 1978 42 44
121. W.O. Shekim, H. Dekirmenjian, J.L. Chapel, J. Javaid, J.M. Davis Norepinephrine metabolism and clinical response to dextroamphetamine in hyperactive boys J Pediatr 95 1979 389 394
122. W.O. Shekim, H. Dekirmenjian, J.L. Chapel Urinary MHPG excretion in minimal brain dysfunction and its modification by d-amphetamine Am J Psychiatry 136 1979 667 671
123. H.B. Ferguson, B.A. Pappas, R.L. Trites, D.A. Peters, H. Taub Plasma free and total tryptophan, blood serotonin, and the hyperactivity syndrome: no evidence for the serotonin deficiency hypothesis Biol Psychiatry 16 1981 231 238
124. A.U. Khan, H. Dekirmenjian Urinary excretion of catecholamine metabolites in hyperkinetic child syndrome Am J Psychiatry 138 1981 108 110
125. W.O. Shekim, J. Javaid, H. Dekirmenjian, J.L. Chapel, J.M. Davis Effects of d-amphetamine on urinary metabolites of dopamine and norepinephrine in hyperactive boys Am J Psychiatry 139 1982 485 488
126. W.O. Shekim, H. Dekirmenjian, J. Javaid, D.B. Bylund, J.M. Davis Dopamine-norepinephrine interaction in hyperactive boys treated with d-amphetamine J Pediatr 100 1982 830 844
127. W.O. Shekim, L.G. Davis, D.B. Bylund, E. Brunngraber, L. Fikes, J. Lanham Platelet MAO in children with attention deficit disorder and hyperactivity: a pilot study Am J Psychiatry 139 1982 936 938
128. W.O. Shekim, J. Javaid, J.M. Davis, D.B. Bylund Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine Biol Psychiatry 18 1983 707 714
129. Y.C. Shen, Y.F. Wang Urinary 3-methoxy-4-hydroxyphenylglycol sulfate excretion in seventy-three schoolchildren with minimal brain dysfunction syndrome Biol Psychiatry 19 1984 861 870
130. A.J. Zametkin, F. Karoum, J.L. Rapoport, G.L. Brown, R.J. Wyatt Phenylethylamine excretion in attention deficit disorder J Am Acad Child Psychiatry 23 1984 310 314
131. Y. Hoshino, Y. Ohno, T. Yamamoto, M. Kaneko, H. Kumashiro Plasma free tryptophan concentration in children with attention deficit disorder Folia Psychiatr Neurol Jpn 39 1985 531 535
132. W.O. Shekim, D.B. Bylund, J. Alexson Platelet MAO and measures of attention and impulsivity in boys with attention deficit disorder and hyperactivity Psychiatry Res 18 1986 179 188
133. C.L. Bowden, C.K. Deutsch, J.M. Swanson Plasma dopamine-beta-hydroxylase and platelet monoamine oxidase in attention deficit disorder and conduct disorder J Am Acad Child Adolesc Psychiatry 27 1988 171 174
134. G. Ionescu, R. Kiehl, L. Ona, F. Wichmann-Kunz Abnormal plasma catecholamines in hyperkinetic children Biol Psychiatry 28 1990 547 550
135. G.B. Baker, R.A. Bornstein, A.C. Rouget, S.E. Ashton, J.C. van Muyden, R.T. Coutts Phenylethylaminergic mechanisms in attention-deficit disorder Biol Psychiatry 29 1991 15 22
136. G.B. Baker, R.A. Bornstein, A.B. Douglass, J.C. Van Muyden, S. Ashton, T.L. Bazylewich Urinary excretion of MHPG and normetanephrine in attention deficit hyperactivity disorder Mol Chem Neuropathol 18 1993 173 178
137. S.R. Pliszka, J.W. Maas, M.A. Javors, G.A. Rogeness, J. Baker Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety J Am Acad Child Adolesc Psychiatry 33 1994 1165 1173
138. N.L. Girardi, S.E. Shaywitz, B.A. Shaywitz Blunted catecholamine responses after glucose ingestion in children with attention deficit disorder Pediatr Res 38 1995 539 542
139. G.L. Hanna, E.M. Ornitz, M. Hariharan Urinary epinephrine excretion during intelligence testing in attention-deficit hyperactivity disorder and normal boys Biol Psychiatry 40 1996 553 555
140. G.L. Hanna, E.M. Ornitz, M. Hariharan Urinary catecholamine excretion and behavioral differences in ADHD and normal boys J Child Adolesc Psychopharmacol 6 1996 63 73
141. R.D. Oades, B. Müller The development of conditioned blocking and monoamine metabolism in children with attention-deficit-hyperactivity disorder or complex tics and healthy controls: an exploratory analysis Behav Brain Res 88 1997 95 102
142. R.D. Oades, R. Daniels, W. Rascher Plasma neuropeptide-Y levels, monoamine metabolism, electrolyte excretion and drinking behavior in children with attention-deficit hyperactivity disorder Psychiatry Res 80 1998 177 186
143. A. Kusaga, Y. Yamashita, T. Koeda Increased urine phenylethylamine after methylphenidate treatment in children with ADHD Ann Neurol 52 2002 372 374
144. K. Konrad, S. Gauggel, J. Schurek Catecholamine functioning in children with traumatic brain injuries and children with attention-deficit/hyperactivity disorder Brain Res Cogn Brain Res 16 2003 425 433
145. S.B. Wigal, D. Nemet, J.M. Swanson Catecholamine response to exercise in children with attention deficit hyperactivity disorder Pediatr Res 53 2003 756 761
146. V. Roessner, A. Weber, A. Becker Decreased serum semicarbazide sensitive aminooxidase (SSAO) activity in patients with major depression Prog Neuropsychopharmacol Biol Psychiatry 30 2006 906 909
147. M. Dvoráková, D. Jezová, P. Blazícek Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): modulation by a polyphenolic extract from pine bark (pycnogenol) Nutr Neurosci 10 2007 151 157
148. V. Roessner, S. Walitza, F. Riederer Tetrahydroisoquinoline derivatives: a new perspective on monoaminergic dysfunction in children with ADHD? Behav Brain Funct 3 2007 64
149. T. Coccini, A. Crevani, G. Rossi Reduced platelet monoamine oxidase type B activity and lymphocyte muscarinic receptor binding in unmedicated children with attention deficit hyperactivity disorder Biomarkers 14 2009 513 522
150. V. Hercigonja Novkovic, V. Rudan, N. Pivac, G. Nedic, D. Muck-Seler Platelet serotonin concentration in children with attention-deficit/ hyperactivity disorder Neuropsychobiology 59 2009 17 22
151. I. Paclt, J. Koudelová, D. Pacltova, M. Kopeckova Dopamine beta hydroxylase (DBH) plasma activity in childhood mental disorders Neuro Endocrinol Lett 30 2009 604 609
152. N. Bhaduri, K. Sarkar, S. Sinha, A. Chattopadhyay, K. Mukhopadhyay Study on DBH genetic polymorphisms and plasma activity in attention deficit hyperactivity disorder patients from Eastern India Cell Mol Neurobiol 30 2010 265 274
153. G. Nedic, N. Pivac, D.K. Hercigonja, M. Jovancevic, K.D. Curkovic, D. Muck-Seler Platelet monoamine oxidase activity in children with attention-deficit/hyperactivity disorder Psychiatry Res 175 2010 252 255
154. R.D. Oades, A.M. Myint, M.R. Dauvermann, B.G. Schimmelmann, M.J. Schwarz Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention Behav Brain Funct 6 2010 32
155. R.D. Oades, M.R. Dauvermann, B.G. Schimmelmann, M.J. Schwarz, A.M. Myint Attention-deficit hyperactivity disorder (ADHD) and glial integrity: S100B, cytokines and kynurenine metabolism - effects of medication Behav Brain Funct 6 2010 29
156. J.T. Nigg, G.M. Knottnerus, M.M. Martel Low blood lead levels associated with clinically diagnosed attention-deficit/hyperactivity disorder and mediated by weak cognitive control Biol Psychiatry 63 2008 325 331
157. H.L. Wang, X.T. Chen, B. Yang Case-control study of blood lead levels and attention deficit hyperactivity disorder in Chinese children Environ Health Perspect 116 2008 1401 1406
158. A.C. Farias, A. Cunha, C.R. Benko Manganese in children with attention-deficit/hyperactivity disorder: relationship with methylphenidate exposure J Child Adolesc Psychopharmacol 20 2010 113 118
159. J.T. Nigg, M. Nikolas, G. Mark Knottnerus, K. Cavanagh, K. Friderici Confirmation and extension of association of blood lead with attention-deficit/hyperactivity disorder (ADHD) and ADHD symptom domains at population-typical exposure levels J Child Psychol Psychiatry 51 2010 58 65
160. L.E. Arnold, N.A. Votolato, D. Kleykamp, G.B. Baker, R.A. Bornstein Does hair zinc predict amphetamine improvement of ADD/hyperactivity? Int J Neurosci 50 1990 103 107
161. M. Bekarolu, Y. Aslan, Y. Gedik Relationships between serum free fatty acids and zinc, and attention deficit hyperactivity disorder: a research note J Child Psychol Psychiatry 37 1996 225 227
162. P. Toren, S. Eldar, B.A. Sela Zinc deficiency in attention-deficit hyperactivity disorder Biol Psychiatry 40 1996 1308 1310
163. T. Kozielec, B. Starobrat-Hermelin Assessment of magnesium levels in children with attention deficit hyperactivity disorder (ADHD) Magnes Res 10 1997 143 148
164. J.R. Chen, S.F. Hsu, C.D. Hsu, L.H. Hwang, S.C. Yang Dietary patterns and blood fatty acid composition in children with attention-deficit hyperactivity disorder in Taiwan J Nutr Biochem 15 2004 467 472
165. E. Konofal, M. Lecendreux, I. Arnulf, M.C. Mouren Iron deficiency in children with attention-deficit/hyperactivity disorder Arch Pediatr Adolesc Med 158 2004 1113 1115
166. J.G. Millichap, M.M. Yee, S.I. Davidson Serum ferritin in children with attention-deficit hyperactivity disorder Pediatr Neurol 34 2006 200 203
167. E. Konofal, S. Cortese, M. Marchand, M.C. Mouren, I. Arnulf, M. Lecendreux Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children Sleep Med 8 2007 711 715
168. O. Yorbik, M.F. Ozdag, A. Olgun, M.G. Senol, S. Bek, S. Akman Potential effects of zinc on information processing in boys with attention deficit hyperactivity disorder Prog Neuropsychopharmacol Biol Psychiatry 32 2008 662 667
169. Viktorinova A, Trebaticka J, Paduchova Z, et al. Natural polyphenols modify trace element status and improve clinical symptoms of attention-deficit hyperactivity disorder [published online October 20, 2009]. Biomed Pharmacother. doi: 10.1016/j.biopha.2009.04.040.
170. M. Menegassi, E.D. Mello, L.R. Guimarães Food intake and serum levels of iron in children and adolescents with attention-deficit/hyperactivity disorder Rev Bras Psiquiatr 32 2010 132 138
171. M. Juneja, R. Jain, V. Singh, V. Mallika Iron deficiency in Indian children with attention deficit hyperactivity disorder Indian Pediatr 47 2010 955 958
172. J.Y. Kiddie, M.D. Weiss, D.D. Kitts, R. Levy-Milne, M.B. Wasdell Nutritional status of children with attention deficit hyperactivity disorder: a pilot study Int J Pediatr 2010 767318
173. E. Archana, P. Pai, B.K. Prabhu, R.P. Shenoy, K. Prabhu, A. Rao Altered biochemical parameters in saliva of pediatric attention deficit hyperactivity disorder Neurochem Res 37 2012 330 334
174. S. Cortese, R. Azoulay, F.X. Castellanos Brain iron levels in attention-deficit/hyperactivity disorder: a pilot MRI study World J Biol Psychiatry 13 2012 223 231
175. G. Irmisch, J. Thome, O. Reis, F. Hässler, S. Weirich Modified magnesium and lipoproteins in children with attention deficit hyperactivity disorder (ADHD) World J Biol Psychiatry 12 Suppl 1 2011 63 65
176. E.A. Mitchell, S. Lewis, D.R. Cutler Essential fatty acids and maladjusted behaviour in children Prostaglandins Leukot Med 12 1983 281 287
177. E.A. Mitchell, M.G. Aman, S.H. Turbott, M. Manku Clinical characteristics and serum essential fatty acid levels in hyperactive children Clin Pediatr (Phila) 26 1987 406 411
178. L.J. Stevens, S.S. Zentall, J.L. Deck Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder Am J Clin Nutr 62 1995 761 768
179. L. Stevens, W. Zhang, L. Peck EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors Lipids 38 2003 1007 1021
180. K. Joshi, S. Lad, M. Kale Supplementation with flax oil and vitamin C improves the outcome of attention deficit hyperactivity disorder (ADHD) Prostaglandins Leukot Essent Fatty Acids 74 2006 17 21
181. M. Germano, D. Meleleo, G. Montorfano Plasma, red blood cells phospholipids and clinical evaluation after long chain omega-3 supplementation in children with attention deficit hyperactivity disorder (ADHD) Nutr Neurosci 10 2007 1 9
182. A.L. Colter, C. Cutler, K.A. Meckling Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study Nutr J 7 2008 8
183. S. Spahis, M. Vanasse, S.A. Bélanger, P. Ghadirian, E. Grenier, E. Levy Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder Prostaglandins Leukot Essent Fatty Acids 79 2008 47 53
184. N. Pivac, A. Knezević, O. Gornik Human plasma glycome in attention-deficit hyperactivity disorder and autism spectrum disorders Mol Cell Proteomics 10 2011 M110.004200
185. M.J. Kruesi, M.E. Schmidt, M. Donnelly, E.D. Hibbs, S.D. Hamburger Urinary free cortisol output and disruptive behavior in children J Am Acad Child Adolesc Psychiatry 28 1989 441 443
186. L.M. Jansen, C.C. Gispen-de Wied, L.M. Jansen, C.C. Gispen-de Wied, M.A. Jansen, R.J. van der Gaag, W. Matthys, H. van Engeland Pituitary-adrenal reactivity in a child psychiatric population: salivary cortisol response to stressors Eur Neuropsychopharmacol 9 1999 67 75
187. H. Snoek, S.H. Van Goozen, W. Matthys, J.K. Buitelaar, H. van Engeland Stress responsivity in children with externalizing behavior disorders Dev Psychopathol 16 2004 389 406
188. M. Blomqvist, K. Holmberg, F. Lindblad, E. Fernell, U. Ek, G. Dahllöf Salivary cortisol levels and dental anxiety in children with attention deficit hyperactivity disorder Eur J Oral Sci 115 2007 1 6
189. C.M. Freitag, S. Hänig, H. Palmason, J. Meyer, S. Wüst, C. Seitz Cortisol awakening response in healthy children and children with ADHD: impact of comorbid disorders and psychosocial risk factors Psychoneuroendocrinology 34 2009 1019 1028
190. E.F. Maldonado, M.V. Trianes, A. Cortés, E. Moreno, M. Escobar Salivary cortisol response to a psychosocial stressor on children diagnosed with attention-deficit/hyperactivity disorder: differences between diagnostic subtypes Span J Psychol 12 2009 707 714
191. D. van West, S. Claes, D. Deboutte Differences in hypothalamic-pituitary- adrenal axis functioning among children with ADHD predominantly inattentive and combined types Eur Child Adolesc Psychiatry 18 2009 543 553
192. H. Christiansen, R.D. Oades, L. Psychogiou, B.P. Hauffa, E.J. Sonuga-Barke Does the cortisol response to stress mediate the link between expressed emotion and oppositional behavior in attention-deficit/hyperactivity- disorder (ADHD)? Behav Brain Funct 6 2010 45
193. L. Ma, Y.H. Chen, H. Chen, Y.Y. Liu, Y.X. Wang The function of hypothalamus-pituitary-adrenal axis in children with ADHD Brain Res 1368 2011 159 162
194. A.M. McCarthy, K. Hanrahan, L.M. Scott, N. Zemblidge, C. Kleiber, M.B. Zimmerman Salivary cortisol responsivity to an intravenous catheter insertion in children with attention-deficit/hyperactivity disorder J Pediatr Psychol 36 2011 902 910
195. L.J. Wang, Y.S. Huang, C.C. Hsiao Salivary dehydroepiandrosterone, but not cortisol, is associated with attention deficit hyperactivity disorder World J Biol Psychiatry 12 2011 99 109
196. L.J. Wang, C.C. Hsiao, Y.S. Huang Association of salivary dehydroepiandrosterone levels and symptoms in patients with attention deficit hyperactivity disorder during six months of treatment with methylphenidate Psychoneuroendocrinology 36 2011 1209 1216
197. R.D. Oades Differential measures of 'sustained attention' in children with attention-deficit/hyperactivity or tic disorders: relations to monoamine metabolism Psychiatry Res 93 2000 165 178
198. W.O. Shekim, E. Sinclair, R. Glaser, E. Horwitz, J. Javaid, D.B. Bylund Norepinephrine and dopamine metabolites and educational variables in boys with attention deficit disorder and hyperactivity J Child Neurol 2 1987 50 56
199. T.D. Eppright, S.J. Vogel, E. Horwitz, H.D. Tevendale Results of blood lead screening in children referred for behavioral disorders Mo Med 94 1997 295 297
200. L. Bax, L.M. Yu, N. Ikeda, H. Tsuruta, K.G.M. Moons Development and validation of MIX: comprehensive free software for meta-analysis of causal research data BMC Med Res Methodol 6 2006 50
201. L. Bax, L.M. Yu, N. Ikeda, N. Tsuruta, K.G.M. Moons MIX: comprehensive free software for meta-analysis of causal research data - version 1.7 http://www.mix-for-meta-analysis.info 2008